What Paxil (Paroxetine) Is Used For
Paxil is FDA-approved to treat major depressive disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, generalized anxiety disorder, and premenstrual dysphoric disorder (PMDD) in adults. 1
FDA-Approved Indications
Paxil has the broadest anxiety disorder indication profile of any SSRI, making it particularly valuable when depression and anxiety coexist:
Major Depressive Disorder (MDD): For prominent depressed mood or loss of interest lasting at least 2 weeks with associated symptoms (sleep changes, appetite changes, fatigue, guilt, concentration problems, or suicidal thoughts) 1
Panic Disorder: For recurrent unexpected panic attacks with palpitations, sweating, trembling, shortness of breath, chest pain, dizziness, or fear of losing control 1
Social Anxiety Disorder (Social Phobia): For marked fear of social or performance situations with exposure to unfamiliar people or scrutiny by others 1
Obsessive-Compulsive Disorder (OCD): Though not explicitly detailed in the provided FDA label excerpts, this is an established indication 2, 3
Post-Traumatic Stress Disorder (PTSD): For trauma-related symptoms 2, 3
Generalized Anxiety Disorder (GAD): For persistent excessive worry 2, 3
Premenstrual Dysphoric Disorder (PMDD): Available in the controlled-release formulation (Paxil CR) 1, 3
Additional Clinical Use
Paroxetine mesylate 7.5 mg is the only FDA-approved non-hormonal treatment for moderate to severe vasomotor symptoms (hot flashes) in postmenopausal women, particularly important for women who cannot or choose not to use hormone therapy 4. This requires lower doses than psychiatric indications, reducing side effect burden.
Clinical Practice Context
The American College of Physicians guidelines establish that when choosing pharmacotherapy for depression, select second-generation antidepressants based on adverse effect profiles, cost, and patient preferences—not efficacy, as all second-generation antidepressants show equivalent effectiveness 5. However, paroxetine's unique advantage is its approval across all five major anxiety disorders plus depression, making it particularly useful when psychiatric comorbidity exists 6.
Critical Safety Warnings
When prescribing Paxil, you must discuss these risks:
Black box warning for suicidality: Increased risk of suicidal thoughts/actions in children, adolescents, and young adults, especially in first few months or with dose changes. Monitor closely within 1-2 weeks of initiation 1
Pregnancy concerns: Associated with increased risk of cardiac birth defects and persistent pulmonary hypertension in newborns 1, 2
Discontinuation syndrome: Paroxetine has the highest risk among SSRIs for withdrawal symptoms (dizziness, electric shock sensations, nausea, emotional lability). Always taper gradually rather than stop abruptly 1
Drug interactions: Paroxetine is the most potent CYP2D6 inhibitor among antidepressants. Never prescribe with tamoxifen—it reduces tamoxifen's cancer-fighting efficacy by 620% in some studies and increases breast cancer mortality risk 7. Also contraindicated with MAOIs, thioridazine, and pimozide 1
Sexual dysfunction: Higher rates than other SSRIs like fluoxetine or sertraline 5
Dosing Considerations
Lower doses (7.5 mg) effectively treat vasomotor symptoms, while psychiatric indications typically require 20-60 mg daily 4, 6. The controlled-release formulation (Paxil CR) improves gastrointestinal tolerability 3. Therapeutic response should be evident within 6-8 weeks; if not, modify treatment 5.